This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Neil Emans: Innovator in Plant Disease Resistance
Introduction
Neil Emans is a notable inventor based in Thimister-Clermont, Belgium. He has made significant contributions to the field of plant pathology through his innovative research and development of molecular solutions for plant disease resistance.
Latest Patents
Neil Emans holds a patent for a "Molecular pathogenicide mediated plant disease resistance." This invention involves a fusion protein that contains at least one binding domain specifically recognizing an epitope of a plant pathogen. Additionally, it includes at least one domain derived from a protein or peptide sequence that is toxic to the pathogen or detrimental to its replication, transmission, or life cycle. The patent also covers pathogenocides made from the binding domain, cellular targeting sequences, and methods for creating pathogen-resistant plants, plant cells, or plant tissues.
Career Highlights
Throughout his career, Neil Emans has worked with prominent organizations such as the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. and RWTH Aachen. His work has focused on developing innovative solutions to combat plant diseases, enhancing agricultural productivity and sustainability.
Collaborations
Neil has collaborated with esteemed colleagues, including Yu-Cai Liao and Sabine Zimmerman, contributing to advancements in plant disease resistance research.
Conclusion
Neil Emans is a pioneering inventor whose work in molecular pathogenicides has the potential to revolutionize plant disease management. His contributions are vital for the future of agriculture and food security.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
